PubMed Health⌕ Search

Biomedical subjects

L Pignide

Publications and source records attributed to L Pignide.

9 recordsLinked to original sources

[Magnesium and the threat of premature labor].

The magnesium ion, which is a bivalent cation and is necessary for life, is a co-factor in more than 300 enzyme reactions. It has an action on uterine myometrium causing it to relax by stimulating B2 adrenergic receptors and cyclical AMP. It competes with the calcium ion which brings about inhibition of myosine kinase, and therefore a drop in phosphorylated myosine. Deficiency of magnesium is one explanation for uterine overactivity; because it is difficult to estimate how important it is in certain premature labours because this is caused often by many factors, and the levels of plasma magnesium and of blood cell magnesium give poor information about the magnesium pool. The tocolytic properties of magnesium are interesting. One has to distinguish between oral magnesium-therapy, given as a preventive from the first trimester of pregnancy, and parenteral magnesium therapy which can be curative and which, like beta-mimetics, is indicated in threatened premature delivery.

Female↗

[Efficacy and limits of magnesium therapy in extrasystole].

This study was carried out on a group of 19 patients with extrasystolic arrhythmia, the origin of which was atrial and/or ventricular. Its mean value was at least one extrasystole per minute. The patients were monitored by Holter for 24 h. In this population, we found a plasmatic and/or erythrocytic hypomagnesemia in two thirds of the patients. The simultaneous finding of an extrasystolic arrhythmia and of a lowering of magnesium values might be a mere coincidence. Treatment with intravenous magnesium salts did not significantly reduce the frequency of extrasystolic beats in any of our patients, utilizing the criteria of Morganroth, which are rather stringent. However, our treatment was beneficial in some cases; we noticed an average decrease of 20% in the extrasystolic beats during the 24-hour period. This response to magnesium treatment is somewhat irregular; some patients do not react at all. On the other hand, 3 patients reacted to our treatment during this period of 24 h with a decrease of 80% in their extrasystolic beats. We did not determine whether this effect remains after these first 24 h. It might be interesting to follow up these arrhythmias for several weeks after magnesium intake treatment, especially in patients having a proven deficiency at the beginning of this treatment. It seems beneficial, a priori, to remedy a magnesium-deficient state in any patient who has a persistent extrasystolic arrhythmia.

Adult↗